SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 M in biochemical kinase assays
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | SKLB610 |
| 分子式 | C21H16F3N3O3 |
| 分子量 | 415.37 |
| InChiKey | |
| InChi | |
| Cas号 | 1125780-41-7 |
| 相关CAS号 | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |